CFB
COLL icon

Cullen/Frost Bankers’s Collegium Pharmaceutical COLL Stock Holding History

Cullen/Frost Bankers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Buy
1,203
+841
+232% +$28.7K ﹤0.01% 900
2026
Q1 		$12K Buy
362
+40
+12% +$1.69K ﹤0.01% 1077
2025
Q4 		$14.9K Buy
+322
New +$13.5K ﹤0.01% 1067

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Cullen/Frost Bankers's COLL Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Collegium Pharmaceutical (COLL) stake by 232% in Q2 2026, buying an estimated $28.7K and bringing the position to 1,203 shares worth $43.5K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Cullen/Frost Bankers first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. 42 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Cullen/Frost Bankers held 1,203 shares of Collegium Pharmaceutical worth $43.5K as of Q2 2026.
  • Cullen/Frost Bankers bought 841 Collegium Pharmaceutical shares in Q2 2026, an estimated $28.7K.
  • Collegium Pharmaceutical made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #900 holding.
  • Cullen/Frost Bankers first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 42 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.